×
For best experience we recommend to activate Javascript in your browser.
MAP1B antibody (AA 2207-2468)
This Rabbit Polyclonal antibody specifically detects MAP1B in IHC, WB, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for MAP1B antibody (AA 2207-2468) (ABIN7622476)
Target
See all MAP1B Antibodies
MAP1B
(Microtubule-Associated Protein 1B (MAP1B))
Reactivity
All reactivities for MAP1B antibodies
Human
Host
All hosts for MAP1B antibodies
Rabbit
Clonality
All clonalities for MAP1B antibodies
Polyclonal
Conjugate
All conjugates for MAP1B antibodies
This MAP1B antibody is un-conjugated
Application
All applications for MAP1B antibodies
Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-MAP1B Antibody
(hide)
Binding Specificity
All epitopes for MAP1B antibodies
AA 2207-2468
Purpose
Microtubule Associated Protein 1B (MAP1B) Polyclonal Antibody
Sequence
Asp2207~Leu2468
Characteristics
The Microtubule Associated Protein 1B (MAP1B) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.24 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for MAP1B
(hide)
Target
MAP1B
(Microtubule-Associated Protein 1B (MAP1B))
Alternative Name
MAP1B
Gene ID
4131
UniProt
P46821
Pathways
Microtubule Dynamics , Regulation of Cell Size
Recently viewed
(hide)
Chat with us , powered by LiveChat